Skip to main content

Table 4 Unadjusted potential predictors of RBV adherence among the study population with available RBV adherence data (n = 86)

From: Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study

 

RBV adherence of 95% (%; n = 59)

RBV adherence of < 95% (%; n = 27)

Unadjusted OR

95% CI

P

Age (years)

  ≤ 41

29 (66)

15 (34)

1.00

-

-

  > 41

30 (71)

12 (29)

1.25

0.50–3.11

0.632

Gender

 Female

49 (69)

22 (31)

1.00

-

-

 Male

10 (67)

5 (33)

1.14

0.35–3.72

0.833

Educationa

  < Tertiary

43 (69)

19 (31)

1.00

-

-

 Tertiary or greater

15 (71)

6 (29)

1.18

0.40–3.48

0.766

Social functioning score

  < 17

29 (76)

9 (24)

1.00

-

-

  ≥ 17

30 (63)

18 (38)

0.53

0.21–1.38

0.195

Current depressionb

 No

24 (65)

13 (35)

1.00

-

-

 Yes

30 (68)

14 (32)

1.11

0.44–2.80

0.818

Hazardous alcohol consumptionc

 No

48 (68)

23 (32)

1.00

-

-

 Yes

8 (67)

4 (33)

0.94

0.26–3.44

0.924

Current OST

 No

16 (64)

9 (36)

1.00

-

-

 Yes

43 (70)

18 (30)

1.26

0.48–3.36

0.638

Injecting (last month)

 No

22 (69)

10 (31)

1.00

-

-

 Yes

37 (69)

17 (31)

0.95

0.37–2.42

0.908

Frequency of injecting (last month)

 Never

22 (69)

10 (31)

1.00

-

-

 Less than weekly

14 (67)

7 (33)

0.87

0.27–2.81

0.815

 Weekly or greater

23 (70)

10 (30)

1.00

0.35–2.86

1.000

Heroin injecting (last month)

 No

35 (66)

18 (34)

1.00

-

-

 Yes

24 (73)

9 (27)

1.33

0.51–3.46

0.554

Cocaine injecting (last month)

 No

52 (68)

24 (32)

1.00

-

-

 Yes

7 (70)

3 (30)

0.77

0.25–4.44

0.940

Amphetamine injecting (last month)

 No

51 (69)

23 (31)

1.00

-

-

 Yes

8 (67)

4 (33)

0.88

0.24–3.24

0.853

Injecting on therapy

 No

25 (74)

9 (26)

1.00

-

-

 Yes

34 (65)

18 (35)

0.65

0.25–1.69

0.380

Therapy duration

 24 weeks

18 (72)

7 (28)

1.00

-

-

 12 weeks

41 (67)

20 (33)

0.80

0.29–2.22

0.664

  1. aMissing data for three participants
  2. bMissing data for five participants
  3. cMissing data for three participants; percentages refer to row percentages